- Home
- GH vs IAG Comparison
GH vs IAG Comparison
Compare GH & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- IAG
- Stock Information
- Founded
- GH 2011
- IAG 1990
- Country
- GH United States
- IAG Canada
- Employees
- GH N/A
- IAG N/A
- Industry
- GH Medical Specialities
- IAG Precious Metals
- Sector
- GH Health Care
- IAG Basic Materials
- Exchange
- GH Nasdaq
- IAG Nasdaq
- Market Cap
- GH 4.9B
- IAG 4.6B
- IPO Year
- GH 2018
- IAG 1996
- Fundamental
- Price
- GH $61.40
- IAG $8.77
- Analyst Decision
- GH Strong Buy
- IAG Buy
- Analyst Count
- GH 16
- IAG 6
- Target Price
- GH $57.50
- IAG $8.61
- AVG Volume (30 Days)
- GH 3.4M
- IAG 12.9M
- Earning Date
- GH 07-30-2025
- IAG 08-07-2025
- Dividend Yield
- GH N/A
- IAG N/A
- EPS Growth
- GH N/A
- IAG 452.66
- EPS
- GH N/A
- IAG 1.37
- Revenue
- GH $828,849,000.00
- IAG $1,966,800,000.00
- Revenue This Year
- GH $23.36
- IAG $52.60
- Revenue Next Year
- GH $21.43
- IAG $13.20
- P/E Ratio
- GH N/A
- IAG $7.04
- Revenue Growth
- GH 28.74
- IAG 57.81
- 52 Week Low
- GH $20.14
- IAG $4.44
- 52 Week High
- GH $62.81
- IAG $8.87
- Technical
- Relative Strength Index (RSI)
- GH 72.00
- IAG 70.29
- Support Level
- GH $57.41
- IAG $7.90
- Resistance Level
- GH $59.92
- IAG $8.30
- Average True Range (ATR)
- GH 2.54
- IAG 0.38
- MACD
- GH 0.99
- IAG 0.10
- Stochastic Oscillator
- GH 92.69
- IAG 94.82
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.